Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders

por Leijdekkers, Jori A, Torrance, Helen L, Schouten, Nienke E, van Tilborg, Theodora C, Oudshoorn, Simone C, Mol, Ben Willem J, Eijkemans, Marinus J C, Broekmans, Frank J M
Publicado 2019

Cumulative live birth rates in low-prognosis women

por Leijdekkers, Jori A, Eijkemans, Marinus J C, van Tilborg, Theodora C, Oudshoorn, Simone C, van Golde, Ron J T, Hoek, Annemieke, Lambalk, Cornelis B, de Bruin, Jan Peter, Fleischer, Kathrin, Mochtar, Monique H, Kuchenbecker, Walter K H, Laven, Joop S E, Mol, Ben Willem J, Torrance, Helen L, Broekmans, Frank J M
Publicado 2019

The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

por van Tilborg, Theodora C, Eijkemans, Marinus JC, Laven, Joop SE, Koks, Carolien AM, de Bruin, Jan Peter, Scheffer, Gabrielle J, van Golde, Ron JT, Fleischer, Kathrin, Hoek, Annemieke, Nap, Annemiek W, Kuchenbecker, Walter KH, Manger, Petra A, Brinkhuis, Egbert A, van Heusden, Arne M, Sluijmer, Alexander V, Verhoeff, Arie, van Hooff, Marcel HA, Friederich, Jaap, Smeenk, Jesper MJ, Kwee, Janet, Verhoeve, Harold R, Lambalk, Cornelis B, Helmerhorst, Frans M, van der Veen, Fulco, Mol, Ben Willem J, Torrance, Helen L, Broekmans, Frank JM
Publicado 2012